COPD Overview + Drugs (Class/Brand/Generic) Flashcards
Clinical presentation
Sputum, cough & dyspnea
Due to adults exposed to damage over time like smoking
Assessments for COPD
Modified British Medical Research Council (mMRC)
COPD Assessment Test (CAT)
Risk of Exacerbations associated with Symptoms
*know table (draw out)
Starting Treatment associated with Risk of Exacerbations (ABCD)
A - bronchodilator *1st! (SABA or SAMA PRN - LABA or LAMA)
B - LABA or LAMA
C - LAMA
D - LAMA or LABA + LAMA (if highly symptomatic) or LABA + ICS (if eos > 300)
Eosinophils predict the benefit from ICS
EOS > 300 cells/microL = expect a good response to ICS treatment
First-line to escalation of treatment
Bronchodilators!
- LABA
- LAMA
Escalation of Treatment: if Exacerbations?
1) LABA + ICS (eos >300) –> LABA + LAMA + ICS (eos >100)
2) LABA + LAMA —->
2a) LABA + LAMA + ICS (eos >100)
2b) roflumilast or azithromycin “former smoker” [use only if eos < 100]
Escalation of Treatment: if Dyspnea?
LABA + LAMA
ipratropium
Class: Short-acting muscarinic antagonists “SAMA”
Atrovent HFA (ipratropium) MDI: 2 puffs QID
+ albuterol
Combivent Respimat MDI: 1 puff QID
*SAMA = short-acting dosed more frequently
tiotropium
Class: Long-acting muscarinic antagonists “LAMA”
Spiriva (tiotropium)
•HandiHaler DPI: 1 cap BID (requires 2 puffs)
•Respimat MDI: 2 puffs daily
\+ olodacterol "LABA" Stiolto Respimat
aclidinium
Class: Long-acting muscarinic antagonists “LAMA”
Tudorza Pressair (aclidinium)
+ formoterol
Duaklir Pressair
glycopyrrolate
Class: Long-acting muscarinic antagonists “LAMA”
glycopyrrolate
+ formoterol “LABA” (Bevespi Aerosphere)
+ formoterol/fluticasone “LABA/ICS” (Breztri Aerosphere)
revefenacin
Class: Long-acting muscarinic antagonists “LAMA”
Yupelri (revefenacin)
umeclidinium
Class: Long-acting muscarinic antagonists “LAMA”
Incruse Ellipta (umeclidinium)
+ vilanterol “LABA” (Anoro Ellipta)
+ vilanterol/fluticasone “LABA/ICS” (Trelegy Ellipta)
salmeterol
Class: Long-acting beta-2 antagonists “LABA”
Serevent Diskus (salmeterol) \+ fluticasone "ICS" (Advair Diskus)
formoterol
Class: Long-acting beta-2 antagonists “LABA”
Perforomist (formoterol)
+ budesonide “ICS” (Symbicort)
vilanterol
Class: Long-acting beta-2 antagonists “LABA”
Breo Ellipta (vilanterol/fluticasone)
LABA + ICS
Respimat Counseling
1) TURN - hold inhaler upright, move base a 1/2 turn towards the arrows
2) OPEN - open cap fully (until it ‘snaps’), breathe out away from the inhaler, close lips around mouthpiece
3) PRESS - press down button while breathing in slowly
- hold breath for 10 seconds or as long as possible
- breathe out gently away from inhaler
- close cover and repeat TOP for 2 inhalations
Dry Powder Inhalers
Diskus, Ellipta, Pressair, Respiclick, Flexihaler
Dry Powder Capsules
HandiHaler
Meter Dosed Inhalers
HFA, Respimat
RediHaler
Is a breath-activated aerosol; has characteristics of MDI & DPI
Spiriva HandiHaler Counseling
- Never swallow the capsules
- Open the DPI by pressing green button
- Insert capsule and close the mouthpiece
- Press the green button ‘once’ - until flat against the base
- Take 2 inhalations from each Spiriva capsule (you will hear a rattle)
How to clean inhalers
Use damp cloth or tissue weekly and prime before use if > 3 days
Tudorza Pressair Counseling
1) Remove protective cap
2) Before putting into mouth, check the window; the dose is ready for inhalation if it changed from °red to green°
3) Breathe out completely then put lips around mouthpiece inhale deeply until you hear the •click• sound
4) Check the window has turned to red (which indicates the full dose has been inhaled correctly)
Rinse mouth after use of what drug class?
Inhaled corticosteroid (ICS)
Name the inhaled long-acting bronchodilators (Beta-2 agonists).
arformoterol (Brovana) formoterol (Perforomist) indacaterol (Arcapta Neohaler) olodaterol (Striverdi Respimat) salmeterol
**LABA
Name the inhaled long-acting bronchodilators (anticholinergic agents)
aclidinium (Tudorza Pressair)
glycopyrrolate (Seebri Breezhaler)
tiotropium bromide (Spiriva)
umeclidinium (Incruse Ellipta)
**LAMA
Roflumilast in the management of COPD
1) administered as a tablet PO
2) causes weight loss
3) increases cAMP levels due to inhibition of PDE-4
indacaterol
Dosing, class, brand?
Dosing: once daily
Class: LABA
Brand: Arcapta Neohaler
arformoterol
Dosing, class, brand?
Dosing: BID via neb
Class: LABA
Brand: Brovana
aclidinium
Dosing, class, brand?
Dosing: BID (breath-actuated)
Class: LAMA
Brand: Tudorza Pressair
umeclidium
Dosing, class, brand?
Dosing: once daily (breath-actuated)
Class: LAMA
Brand: Incruse Ellipta
Severity of Post-Bronchodilator Airflow Limitation Grades (pg. 597)
Gold 1 - FEV1 80% or higher
Gold 2 - FEV1 50-79% or higher
Gold 3 - FEV1 30–49% or higher
Gold 4 - FEV1 <30%
REMS medications
macitentan (Opsumit)
riociguat (Adempas)
bosentan (Tracleer)
boxed warning: embryo-fetal toxicity
Target O2 sat in patient using supplement oxygen in acute COPD management
88-92%
pt w/ COPD usually live at a lower O2 sat